They concluded that therapeutic interventions that inhibit the endothelial delivery of LDL into the arterial vials mediated by SRB-1 and DOCK 4 may be a potential remedy against the development of atherosclerosis and cardiovascular disease. The gene discussed is SCARB1; the disease is atherosclerosis.